Melatonin and epileptic seizures in patients with acute intermittent porphyria

Epileptic Disorders

Volumn 2, Issue 4, 2000, Pages 203-208

  Bylesjo I ^a   Forsgren, L ^a   Wetterberg, L ^a  

^a Skelleftea Hospital   (Sweden)

Author keywords

Acute intermittent porphyria; Epileptic seizures; Melatonin

Indexed keywords

AMILORIDE; ANTICONVULSIVE AGENT; BUDESONIDE; COCODAMOL; CYANOCOBALAMIN; DIAZEPAM; DIENESTROL; ESTRADIOL; FELODIPINE; FUROSEMIDE; HUMAN GROWTH HORMONE; LEVOTHYROXINE; LISINOPRIL; LYNESTRENOL; MELATONIN; METOPROLOL; PHENOBARBITAL; PHENYTOIN; PRAZOSIN; PROPRANOLOL; TERBUTALINE SULFATE; VALPROIC ACID; VIGABATRIN;

ACUTE INTERMITTENT PORPHYRIA; ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; EPILEPSY; EPILEPTOGENESIS; FEMALE; HORMONE SYNTHESIS; HORMONE URINE LEVEL; HUMAN; NEUROPROTECTION; PRIORITY JOURNAL; SEIZURE; URINARY EXCRETION;

ADULT; AGED; AGED, 80 AND OVER; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 11; EPILEPSY; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; PINEAL GLAND; POINT MUTATION; PORPHYRIA, ACUTE INTERMITTENT;

EID: 0034487613     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. The porphyrias
2. Biochemistry of porphyria
3. Acute intermittent porphyria: A clinical and biochemical study of 46 patients
4. Epidemiology and clinical characteristics of seizures in patients with acute intermittent porphyria
5. Endocrine aspects of the mammalian pineal gland: A review
6. Extra-reproductive effects
7. Broadway light and melatonin as zeitgebers in man
8. Melatonin: A chronobiotic with anti-aging properties
9. Melatonin synthesis: Adenosine 3′,5′-monophosphate and norepinephrine stimulate N-acetyltransferase
10. Control of circadian change in serotonin N-acetyltransferase activity in the pineal organ by the beta-adreneric receptor
11. Genetic regulation of melatonin excretion in urine
12. Age-dependent reduction of serum melatonin concentrations in healthy human subjects
13. A multinational study of the relationships between night-time urinary melatonin production, age, gender, body size, and latitude
14. Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animals
15. Absence of circadian variations in urinary porphyrin excretion in normal subiects
16. Muscular spasms and death in thyroparathyriodectomized rats subjected to pinealectomy
17. Circadian, seasonal, pineal, and melatonin influences on epilepsy
18. Epileptogenic action on intraventricularly injected anti-melatonin antibody
19. The anticonvulsive properties of melatonin on kindled seizures in rats
20. On the effect of melatonin upon human brains: Its possible therapeutic implications
21. Melatonin as a proconvulsive hormone in humans
22. Epilepsy and the sleeping-waking cycle
23. Melatonin in the chicken brain: Its origin, diurnal variation and regional distribution
24. A serum melatonin rhythm in chickens and its abolition by pinealectomy
25. Pineal melatonin rhythm reduction in aging Syrian hamsters
26. 24-Hours profile of melatonin, cortisol, insulin, C-peptide and GIP following a meal and subsequent fasting
27. Melatonin secretion assessed by measuring its metabolite, 6-sulfatoxymelatonin
28. The occurrence and determination of delta aminolevulinic acid and porphobilinogen in urine
29. Guidelines for Epidemiologic Studies on Epilepsy
30. Proposal for revised clinical and electroencephalographic classification of epileptic seizures
31. A simplified radio-immunoassay for melatonin and its application to biological fluids. Preliminary observations on the half-life of plasma melatonin in man
32. Melatonin in serum and urine in patients with idiopathic pain syndromes
33. Melatonin in epilepsy: First results of replacement therapy and first clinical results
34. Melatonin inhibits iron-induced epileptic discharges in rats by suppressing peroxidation
35. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: Two years' experience
36. Diurnal variations of benzodiazepine binding in rat cerebral cortex: Disruption by pinealectomy
37. Changes in gamma-aminobutyric acid high affinity binding to cerebral cortex membranes after pinealectomy or melatonin administration to rats
38. Melatonin: Effects on brain function
39. Melatonin stimulates brain glutathione peroxidase activity
40. Neurohormone melatonin prevents cell damage: Effect on gene expression for antioxidant enzymes
41. Functional pleiotropy of the neurohormone melatonin: Antioxidant protection and neuroendocrine regulation
42. Glutamate, nitric oxide and cell-cell signalling in the nervous system
43. Melatonin is a scavenger of peroxynitrite
44. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum
45. Melatonin reduces nitric oxide synthase activity in rat hypothalamus
46. Pro-convulsant effects of oral melatonin in neurologically disabled children
47. Melatonin response in active epilepsy
48. Ionic mechanism of neuronal excitation by inhibitory GABAA receptors
49. D-aminolevulinic acid: Influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria
50. Acute hepatic haem depletion: Impaired gluconeogenesis in rats
51. Tryptophan pyrrolase in haem regulations
52. Decreased nocturnal plasma melatonin levels in patients with recurrent acute intermittent porphyria attacks
53. Increased 5-aminolevulinic acid and decreased pineal melatonin production
54. Paradoxical effects of melatonin on spontaneous neuronal activity in the striatum of sham-operated and pinealectomized rats
55. Pineal modulation of the rat caudate-putamen neuronal activity: Roles of melatonin and vasotocin
56. Cell protective role of melatonin in the brain
57. Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-D-aspartate excitotoxicity